ATE230983T1 - Neue verwendung von kreatin - Google Patents

Neue verwendung von kreatin

Info

Publication number
ATE230983T1
ATE230983T1 AT97951157T AT97951157T ATE230983T1 AT E230983 T1 ATE230983 T1 AT E230983T1 AT 97951157 T AT97951157 T AT 97951157T AT 97951157 T AT97951157 T AT 97951157T AT E230983 T1 ATE230983 T1 AT E230983T1
Authority
AT
Austria
Prior art keywords
creatine
new use
new
Prior art date
Application number
AT97951157T
Other languages
English (en)
Inventor
Marco Anelli
Ettore Strumia
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11375243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE230983(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Application granted granted Critical
Publication of ATE230983T1 publication Critical patent/ATE230983T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97951157T 1996-11-19 1997-11-10 Neue verwendung von kreatin ATE230983T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI002408A IT1298420B1 (it) 1996-11-19 1996-11-19 Uso della creatina nell'insufficienza cardio-respiratoria
PCT/EP1997/006225 WO1998022099A2 (en) 1996-11-19 1997-11-10 New use of creatine

Publications (1)

Publication Number Publication Date
ATE230983T1 true ATE230983T1 (de) 2003-02-15

Family

ID=11375243

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97951157T ATE230983T1 (de) 1996-11-19 1997-11-10 Neue verwendung von kreatin

Country Status (13)

Country Link
US (1) US6242490B1 (de)
EP (1) EP0941081B1 (de)
CN (2) CN1237904A (de)
AR (1) AR009425A1 (de)
AT (1) ATE230983T1 (de)
BR (1) BR9713514A (de)
DE (1) DE69718506T2 (de)
DK (1) DK0941081T3 (de)
ES (1) ES2191206T3 (de)
IT (1) IT1298420B1 (de)
PT (1) PT941081E (de)
RU (1) RU2202345C2 (de)
WO (1) WO1998022099A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3384539B2 (ja) * 1997-09-05 2003-03-10 義之 内田 喘息治療剤
EP1051914A1 (de) * 1999-05-08 2000-11-15 DSM Fine Chemicals Austria GmbH Verwendung von Kreatin als Futterzusatz
US9833427B2 (en) * 2000-09-14 2017-12-05 Board Of Regents Of The University Of Nebraska Creatine ester anti-inflammatory compounds and formulations
US20030212136A1 (en) * 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
US20030212130A1 (en) * 2000-09-14 2003-11-13 Miller Donald W. Creatine ester anti-inflammatory compounds and formulations
US20040013732A1 (en) * 2001-09-25 2004-01-22 Michael Farber Starch-based delivery system for creatine
US20080160086A1 (en) * 2004-02-19 2008-07-03 Scepter Holdings, Inc. Delivery Systems For Calcium
US20060025475A1 (en) * 2004-07-29 2006-02-02 Stanley Antosh Use of methyl pyruvate for the purpose of increasing muscle energy production.
US20060052448A1 (en) * 2004-09-04 2006-03-09 Mr. Stanley Antosh Use of methyl pyruvate or methyl pyruvic acid for the treatment of diseases of the nervous system and for protecting a human central nervous system against neuronal degeneration caused by defective intracellular energy production.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244534B1 (de) * 1973-06-27 1977-07-01 Biotherax Lab
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
AU3086897A (en) * 1996-06-28 1998-01-21 Ipr-Institute For Pharmaceutical Research Ag Drug preparations, containing creatine with at least one salt of calcium, magnesium, manganese or zinc

Also Published As

Publication number Publication date
ITMI962408A1 (it) 1998-05-19
AR009425A1 (es) 2000-04-12
PT941081E (pt) 2003-04-30
US6242490B1 (en) 2001-06-05
WO1998022099A3 (en) 1998-07-09
ES2191206T3 (es) 2003-09-01
EP0941081A2 (de) 1999-09-15
CN1623534A (zh) 2005-06-08
DE69718506D1 (de) 2003-02-20
DE69718506T2 (de) 2003-07-31
BR9713514A (pt) 2000-02-29
ITMI962408A0 (it) 1996-11-19
CN1237904A (zh) 1999-12-08
IT1298420B1 (it) 2000-01-05
RU2202345C2 (ru) 2003-04-20
EP0941081B1 (de) 2003-01-15
WO1998022099A2 (en) 1998-05-28
DK0941081T3 (da) 2003-04-22

Similar Documents

Publication Publication Date Title
DE69725205D1 (de) Befestigung von Biomolekülen
DE69718393D1 (de) Befestigung von Biomolekülen
DE69715827T2 (de) Verwendung von aloe extrakt enthaltenden zahnprothesehaftmitteln
DE69533361D1 (de) Umsetzung von kohlenwasserstoffen
DE69527527D1 (de) Verwendung von omega-hydrofluoralkylether
DE59905858D1 (de) Verwendung von pit-emulsionen
DE69732684D1 (de) Automatische Modifizierung von Dokumentgestaltungen
DE69720111T2 (de) Vorläufer von Duftstoffen
DE69518454T2 (de) Abschätzung von Anregungsparametern
DE69628195D1 (de) Verwendung von xyloglucanendotransglycosylase
ATE288207T1 (de) Verwendung von 1-nonen-3-one als aromastoff
DE69531048D1 (de) Verwendung von steroidsulphatase-hemmern
DE69718506D1 (de) Neue verwendung von kreatin
DE69717677D1 (de) Koproduktion von perfluormethylperfluorvinylether und perfluorethylperfluorvinylether
DE69500881D1 (de) Oxidation von uranhexafluorid
DE69519381D1 (de) Modifizierung von ölen
DE69513864T2 (de) Verwendung von Polyketon /HDPE Mischungen
DE59705708D1 (de) Lagebestimmung von peripherieeinheiten
DE69711223T2 (de) Verwendung von cordia dichotoma extrakten
DE69522582T2 (de) NEUE VERWENDUNGEN VON INDOLO-[2,3b]-CHINOXALINEN
DE69602155D1 (de) Verbesserung von Branntweinen
DE19781649T1 (de) Herstellung von länglichen Elementen
DE59700206D1 (de) Verwendung von Schichtsilikaten
DE59807752D1 (de) Verwendung von wasserverdünnbaren beschichtungszusammensetzungen
DE59501871D1 (de) Monocarbonsäureamide von Polyaminen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0941081

Country of ref document: EP

REN Ceased due to non-payment of the annual fee
RZN Patent revoked
RZN Patent revoked